B-Cell Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014 -





Published: February 2014 | Pages: 107 | Format: PDF

Summary 

Our clinical trial report, “B-Cell Hodgkin Lymphoma Global Clinical Trials Review, H1, 2014" provides data on the B-Cell Hodgkin Lymphoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on B-Cell Hodgkin Lymphoma . It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating B-Cell Hodgkin Lymphoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts. 

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. 

Scope 

 

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations 
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type 
  • Listings of discontinued trials (suspended, withdrawn and terminated) 

 

Reasons to buy 

 

  • Understand the dynamics of a particular indication in a condensed manner 
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more 
  • Obtain discontinued trial listing for trials across the globe 
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies 

 

Table of Contents 

List of Tables 

List of Figures 

Introduction 

B-Cell Hodgkin Lymphoma 

Report Guidance 

Clinical Trials by Region 

Clinical Trials and Average Enrollment by Country 

Top Countries Contributing to Clinical Trials in Europe 

Top Countries Contributing to Clinical Trials in North America 

Clinical Trials by G7 Countries: Proportion of B-Cell Hodgkin Lymphoma to Oncology Clinical Trials 

Clinical Trials by Phase in G7 Countries 

Clinical Trials in G7 Countries by Trial Status 

Clinical Trials by Phase 

In Progress Trials by Phase 

Clinical Trials by Trial Status 

Unaccomplished Trials of B-Cell Hodgkin Lymphoma 

Subjects Recruited Over a Period of Time 

Clinical Trials by Sponsor Type 

Prominent Sponsors 

Top Companies Participating in B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials 

Prominent Drugs 

Clinical Trial Profiles 

Clinical Trial Overview of Top Companies 

Teva Pharmaceutical Industries Limited 

Clinical Trial Overview of Teva Pharmaceutical Industries Limited 

Incyte Corporation 

Clinical Trial Overview of Incyte Corporation 

Clinical Trial Overview of Top Institutes / Government 

National Cancer Institute 

Clinical Trial Overview of National Cancer Institute 

Fred Hutchinson Cancer Research Center 

Clinical Trial Overview of Fred Hutchinson Cancer Research Center 

German Hodgkin Study Group 

Clinical Trial Overview of German Hodgkin Study Group 

The University of Texas M. D. Anderson Cancer Center 

Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 

Rutgers, The State University of New Jersey 

Clinical Trial Overview of Rutgers, The State University of New Jersey 

University of Nebraska 

Clinical Trial Overview of University of Nebraska 

Case Comprehensive Cancer Center 

Clinical Trial Overview of Case Comprehensive Cancer Center 

Five Key Clinical Profiles 

Appendix 

Abbreviations 

Definitions 

Research Methodology 

Secondary Research 

About Us 

Contact Us 

Disclaimer 

Source  

 

List of Tables 

B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Countries, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2014- 

Proportion of B-Cell Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, Global, Suspended Clinical Trials, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 

B-Cell Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Incyte Corporation, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by German Hodgkin Study Group, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Rutgers, The State University of New Jersey, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Nebraska, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2014-  

 

List of Figures 

B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Countries (%), 2014- 

Proportion of B-Cell Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2014- 

Therapeutics, Global, Clinical Trials In Progress by Phase, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 

B-Cell Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014- 

B-Cell Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014- 

GlobalData Methodology